A look at our second year of practice.

President Philippe Lucas presents the findings of the Global Psychedelic Survey.

Explore how psychedelic neuroscience has helped to inform the emerging science of consciousness with Sidath Rankaduwa and discover a few philosophical issues that arise when we try to understand consciousness through the lens of psychedelics. Sidath will investigate questions such as: To what extent is the psychedelic state a "higher state" of consciousness? And what would it mean for a conscious state to be a "higher" state?

PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — is pleased to share its 2023 White Paper on the future of psychedelic access in Canada: Beyond the Special Access Program — Regulatory Analysis and Recommendations on Psychedelic Access in Canada.

PsyPost’s recent online article featured the results of the Canadian Psychedelic Survey (CPS) and a new publication “Changed Substance Use After Psychedelic Experiences Among Individuals in Canada” from co-authors Philippe Lucas (SABI Mind), Kevin Boehnke and Dan Kruger from UMich.

FRAME Magazine coverage of SABI Mnd Calgary Healing Centre design inspiration.

Heesoo Cho: Transforming Silently, Finding Heritage, and Patient-First Ketamine Assisted Psychotherapy

AWE, or awe-inspiring experience, refers to experiences characterized by feelings of amazement, reverence, and wonder. AWE is considered an important concept in psychedelic psychotherapy, with many individuals undergoing treatment reporting experiencing profound feelings of AWE.

Adults around the world with direct experiences with psychedelics can participate in the historic Global Psychedelic Survey and help shape the future of psychedelic research and policy.

This week, he and Dr. Stephanie Lake PhD (UCLA) will launch the even more ambitious Global Psychedelic Survey (GPS), which he hopes will draw more than 15,0000 respondents from around the world.

SABI Mind Releases Global Psychedelic Survey: The World's Most Comprehensive Assessment of Global Psychedelic Use Adults around the world with direct experiences with psychedelics can participate in the historic Global Psychedelic Survey and help shape the future of psychedelic research and policy

On May 31 from 7:30pm - 8:30pm MST, Gabriel Shaw, will be hosting a virtual discussion and presentation specifically for health practitioners, or those that are struggling with burnout in the health space.

Psychedelic Integration: The Key to Lasting Benefits

Dr. Jessica McLachlan is a Registered Psychologist. She holds a Ph.D. in Clinical Psychology from the University of Calgary.

SABI Mind, an Alberta-based clinic, is participating in a first-of-its-kind study exploring how psilocybin may help treat alcohol use disorder.

Current and Critical Episode 320 - Philippe Lucas, The Evolution of the Psychedelic Therapy Sector

Dr. Lauren Zanussi, Psychiatric lead at SABI Mind discusses Canada’s only clinical trial using Psilocybin to treat alcohol use disorder.

SABI Mind receives approval from the Health Research Ethics Board of Alberta (HREBA) to launch study sponsored by Clairvoyant Therapeutics investigating Psilocybin Assisted Psychotherapy for the treatment of alcohol use disorder.

Calgary Herald Op-Ed: The new regulations governing psychedelic-assisted therapy treatments exclusively to psychiatrists and restrict access to patients.

A look back at the SABI's journey over the past year and the achievements that have helped to bring a new kind of healing to those in need.

An ongoing series that highlights the specialists who make up the multidisciplinary team behind the SABI Mind Method.